SlideShare une entreprise Scribd logo
1  sur  13
RYAN MILLS, PHARM.D CANDIDATE Pharmacist  role in MTM at Charleston Area Medical Center Switching patients Intravenous to oral
Quick Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Goals ,[object Object],[object Object],[object Object]
Background Information ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Drug Utilization Evaluation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Criteria for Switch ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Switch Therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Policy and Procedures ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Methods
Follow-up Evaluation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Limitations ,[object Object],[object Object],[object Object],[object Object]
Conclusion ,[object Object],[object Object],[object Object]
References ,[object Object],[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
pavithra vinayak
 
Therapeutic drug monitoring final
Therapeutic drug monitoring finalTherapeutic drug monitoring final
Therapeutic drug monitoring final
saiesh_phaldesai
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
Naser Tadvi
 

Tendances (20)

1. Introduction to clinical pharmacokinetics
1. Introduction to clinical pharmacokinetics1. Introduction to clinical pharmacokinetics
1. Introduction to clinical pharmacokinetics
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
TDM for B Pharm practical-2019
TDM for B Pharm practical-2019TDM for B Pharm practical-2019
TDM for B Pharm practical-2019
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003
 
Indications of TDM
Indications of TDMIndications of TDM
Indications of TDM
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Pharmacometrics
PharmacometricsPharmacometrics
Pharmacometrics
 
Bayesian theory
Bayesian theoryBayesian theory
Bayesian theory
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
 
Therapeutic drug monitoring and shortcoming in tanzania
Therapeutic drug monitoring and shortcoming in tanzaniaTherapeutic drug monitoring and shortcoming in tanzania
Therapeutic drug monitoring and shortcoming in tanzania
 
Therapeutic drug monitoring final
Therapeutic drug monitoring finalTherapeutic drug monitoring final
Therapeutic drug monitoring final
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Population pharamacokinetics
Population pharamacokineticsPopulation pharamacokinetics
Population pharamacokinetics
 
Design of Dosage form
Design of Dosage formDesign of Dosage form
Design of Dosage form
 
Therapeutic drug monitoring
Therapeutic  drug monitoringTherapeutic  drug monitoring
Therapeutic drug monitoring
 

Similaire à Iv To Po Pp[1]

Transforming the Office Management of Heart Failure Using the Chronic Disease...
Transforming the Office Management of Heart Failure Using the Chronic Disease...Transforming the Office Management of Heart Failure Using the Chronic Disease...
Transforming the Office Management of Heart Failure Using the Chronic Disease...
MedicineAndHealthUSA
 
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNPEVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
BetseyCalderon89
 
08 Am09 Presentations Kliger
08 Am09 Presentations   Kliger08 Am09 Presentations   Kliger
08 Am09 Presentations Kliger
Simon Prince
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
Todd Berner MD
 
Fronzi (Ghc)
Fronzi (Ghc)Fronzi (Ghc)
Fronzi (Ghc)
TORC
 
Genesis Presentation
Genesis PresentationGenesis Presentation
Genesis Presentation
Hai Duong
 
Diuretic strategies in patients with acute decompensated
Diuretic  strategies  in  patients  with  acute  decompensatedDiuretic  strategies  in  patients  with  acute  decompensated
Diuretic strategies in patients with acute decompensated
Warawut Ia
 

Similaire à Iv To Po Pp[1] (20)

Pharmacoeconomic Evaluation of an Antibiotic Streamlining Service
Pharmacoeconomic Evaluation of an Antibiotic Streamlining ServicePharmacoeconomic Evaluation of an Antibiotic Streamlining Service
Pharmacoeconomic Evaluation of an Antibiotic Streamlining Service
 
Introduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementIntroduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout management
 
Transforming the Office Management of Heart Failure Using the Chronic Disease...
Transforming the Office Management of Heart Failure Using the Chronic Disease...Transforming the Office Management of Heart Failure Using the Chronic Disease...
Transforming the Office Management of Heart Failure Using the Chronic Disease...
 
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
 
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNPEVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
 
ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015
 
Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)
 
The Healthcare Team as the Healthcare Provider: A Different View of the Patie...
The Healthcare Team as the Healthcare Provider: A Different View of the Patie...The Healthcare Team as the Healthcare Provider: A Different View of the Patie...
The Healthcare Team as the Healthcare Provider: A Different View of the Patie...
 
Overuse of Stress Ulcer prophylaxis (SUP)
Overuse of Stress Ulcer prophylaxis (SUP)Overuse of Stress Ulcer prophylaxis (SUP)
Overuse of Stress Ulcer prophylaxis (SUP)
 
Value of secondary prevention in cardiac rehabilitation
Value of secondary prevention in cardiac rehabilitationValue of secondary prevention in cardiac rehabilitation
Value of secondary prevention in cardiac rehabilitation
 
American Public Health Association- Annual Meeting 2014 Presentation
American Public Health Association- Annual Meeting 2014 Presentation American Public Health Association- Annual Meeting 2014 Presentation
American Public Health Association- Annual Meeting 2014 Presentation
 
08 Am09 Presentations Kliger
08 Am09 Presentations   Kliger08 Am09 Presentations   Kliger
08 Am09 Presentations Kliger
 
How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World Trials
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
 
Fronzi (Ghc)
Fronzi (Ghc)Fronzi (Ghc)
Fronzi (Ghc)
 
Clinical audit by Dr A. K. Khandelwal
Clinical audit  by Dr A. K. KhandelwalClinical audit  by Dr A. K. Khandelwal
Clinical audit by Dr A. K. Khandelwal
 
Genesis Presentation
Genesis PresentationGenesis Presentation
Genesis Presentation
 
Diuretic strategies in patients with acute decompensated
Diuretic  strategies  in  patients  with  acute  decompensatedDiuretic  strategies  in  patients  with  acute  decompensated
Diuretic strategies in patients with acute decompensated
 
DFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practiceDFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practice
 
Rx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhallRx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhall
 

Iv To Po Pp[1]

  • 1. RYAN MILLS, PHARM.D CANDIDATE Pharmacist role in MTM at Charleston Area Medical Center Switching patients Intravenous to oral
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 10.
  • 11.
  • 12.
  • 13.